AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vaxcyte, Inc. Director's Dealing 2022

Apr 11, 2022

31100_dirs_2022-04-11_e0dafdaf-9f97-4cc1-9279-3f7c3947277a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2022-04-01

Reporting Person: Eydelman Mikhail (SVP, Gen Counsel & Corp Sec)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities owned.	0	Direct